Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |